Poorer survival outcomes in patients with multiple versus single primary melanoma.
Lilit KarapetyanXi YangAndrew D KnightZiyu HuangHong WangCindy A SanderChristopher P MinnierMelissa WilsonAofei LiArivarasan KarunamurthyWalter J StorkusJohn M KirkwoodPublished in: Cancer (2022)
Patients with MPMs had worse RFS and OS compared with patients with SPMs. Immunologic differences were also observed, including TIL content and expression of CXCL6/FOXJ1 in PBMCs of patients with MPMs, which warrant further investigation.